Health Canada approves new antibody drug to help prevent serious RSV in babies

Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.

Monoclonal antibodies are made in a laboratory to mimic natural antibodies to prevent or treat diseases. "It's a game-changer," said Dr. Anna Banerji, a pediatric infectious disease specialist at the University of Toronto's Dalla Lana School of Public Health.Many become seriously ill each year and have to be transported out of remote communities to hospitals in the south, she said.Although Health Canada has authorized nirsevimab for all infants, it's not known whether it will be that widely administered.

On Friday, the CADTH website said its review of the "cost-effectiveness of nirsevimab for prevention of respiratory syncytial virus outcomes in infants" is "in progress."

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

‘It’s a game-changer’: New drug to protect babies from RSV approved - National | Globalnews.caHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Source: GlobalNational - 🏆 81. / 51 Read more »

First Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths - Terrace StandardFirst Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths
Source: TerraceStandard - 🏆 24. / 68 Read more »